Skip to Main Content

Key Action Statement Profile: KAS 5B

Aggregate evidence quality Grade B 
Benefits Decreased frequency of AOM. Ability to treat AOM with topical antibiotic therapy. 
Risks, harms, cost Risks of anesthesia or surgery. Cost. Scarring of TM, chronic perforation, cholesteatoma. Otorrhea. 
Benefits-harms assessment Equilibrium of benefit and harm. 
Value judgments None. 
Intentional vagueness Option based on limited evidence. 
Role of patient preferences Joint decision of parent and clinician. 
Exclusions Any contraindication to anesthesia and surgery. 
Strength Option 
Aggregate evidence quality Grade B 
Benefits Decreased frequency of AOM. Ability to treat AOM with topical antibiotic therapy. 
Risks, harms, cost Risks of anesthesia or surgery. Cost. Scarring of TM, chronic perforation, cholesteatoma. Otorrhea. 
Benefits-harms assessment Equilibrium of benefit and harm. 
Value judgments None. 
Intentional vagueness Option based on limited evidence. 
Role of patient preferences Joint decision of parent and clinician. 
Exclusions Any contraindication to anesthesia and surgery. 
Strength Option 
Close Modal

or Create an Account

Close Modal
Close Modal